Stay updated on Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. No substantive changes to study details or page functionality were observed.SummaryDifference0.0%

- Check27 days agoChange DetectedUI and metadata updates include a Show glossary toggle and new labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. These changes do not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with Texas and updated to revision v3.3.3. Removed the old Texas Locations label and the HHS Vulnerability Disclosure link (from v3.3.2).SummaryDifference0.2%

- Check92 days agoChange DetectedA new revision label Revision: v3.3.2 was added and Revision: v3.2.0 was removed, indicating a minor version update to the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.